Mergers & Acquisitions


Current filters:


Popular Filters

780 to 804 of 930 results

Johnson & Johnson to set up innovation centers to accelerate partnering


US health care giant Johnson & Johnson (NYSE: JNJ) yesterday said it plans to establish four regional…

Johnson & JohnsonLicensingMergers & AcquisitionsPharmaceuticalResearch

Bionomics buys US cancer stem cell firm Eclipse Therapeutics


Australian biotech firm Bionomics (ASX: BNO) has expanded its presence in the USA with the acquisition…

BionomicsBiotechnologyEclipse TherapeuticsMergers & AcquisitionsOncology

Pfizer launches generics JV in China with Hisun


Global drugs behemoth Pfizer (NYSE: PFE) and Zhejiang Hisun Pharmaceuticals (SSE Code: 600267), a leading…

Asia-PacificGenericsHisun-PfizerMergers & AcquisitionsPfizerPharmaceuticalZhejiang Hisun Pharma

Japan's vulnerable pharma companies, by P Reed Maurer


Once upon a time Japan's pharma companies could be compared to a convoy of ships. The big and small,…

Asia-PacificLicensingManagementMarkets & MarketingMergers & AcquisitionsPharmaceutical

Jazz Pharma sells women's health business to Meda for $95 million


US drugmaker Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced a definitive agreement to sell its women's…

Jazz PharmaceuticalsMedaMergers & AcquisitionsPharmaceuticalWomen's Health

Valeant on the prowl again, with bid to buy Medicis for about $2.6 billion


In a sixth acquisition so far this year, as well as several takeovers the previous year, Canada's Valeant…

DermatologicalsMedicis PharmaceuticalMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals

Mitsubishi Tanabe to take full control of Bipha JV


Japanese drug major Mitsubishi Tanabe Pharma (TYO: 4508) has agreed to acquire the 49% holding (20,580…

Bipha CorpMergers & AcquisitionsMitsubishi TanabePharmaceutical

Synergy Pharma gains rights to shingles drug from Bristol-Myers


US biopharma firm Synergy Pharmaceuticals (Nasdaq: SGYP) has signed an asset purchase agreement with…

Anti-viralsBiotechnologyBristol-Myers SquibbFV-100Mergers & AcquisitionsSynergy Pharmaceuticals

Merck KGaA acquires cell culture media specialist Biochrom


Germany's Merck KGaA (MRK: DE) announced yesterday that it has entered into definitive agreements to…

BiochromMerck KGaAMergers & AcquisitionsMilliporePharmaceutical

United Drug acquires Bilcare clinical trials materials business


Ireland-based health care services company United Drug (UDG: IR) announced yesterday that it has reached…

BilcareMergers & AcquisitionsPharmaceuticalUnited Drug

Cinven to acquire Mercury Pharma for $730 million


Cinven, a Channel Islands-based private equity firm, said last Friday that it has reached agreement to…

CinvenGenericsMercury PharmaMergers & AcquisitionsPharmaceutical

Stada Arz sells two Russian production facilities


German drugmaker Stada Arzneimittel (SAZ: GR) revealed this week that it has signed a contract and accompanying…

EuropeGenericsMergers & AcquisitionsPharmaceuticalProductionSTADA Arzneimittel

Aspen Pharmacare acquires portfolio from GSK in Australia for £172 million


South Africa headquartered Aspen Pharmacare (APN: SJ) revealed this morning that it has reached agreement…

Asia-PacificAspen PharmacareGlaxoSmithKlineMergers & AcquisitionsPharmaceutical

Cortex and Pier Pharma in all-share merger


USA-based neuroscience company Cortex Pharmaceuticals (OTCBB: CORX) and privately held biotech firm Pier…

BiotechnologyCortex PharmaceuticalsMergers & AcquisitionsNeurologicalPharmaceuticalPier Pharmaceuticals

Sun Pharma finally succeeds in Taro takeover with increased offer


Indian drugmaker Sun Pharmaceutical Industries (SUN: BO) says that it has now reached agreement to acquire…

GenericsMergers & AcquisitionsSun Pharmaceutical IndustriesTaro Pharmaceuticals

MEI Pharma to acquire S*BIO's pracinostat


US cancer drug developer MEI Pharma (Nasdaq: MEIP) has entered into a definitive asset purchase agreement…

BiotechnologyMEI PharmaMergers & AcquisitionsOncologyPharmaceuticalpracinostatS*BIO

Japan's Fuji Pharma to buy Thai contract manufacturer for $54 million


Japanese drugmaker Fuji Pharma says it has entered into an agreement with Switzerland's DKSH to acquire…

Asia-PacificFuji PharmaMergers & AcquisitionsOLICPharmaceuticalProduction

OPKO buys Farmadiet to gain presence in Europe


Making its third acquisition this year, USA-based OPKO Health (NYSE: OPK) said on Friday that it has…

FarmadietMergers & AcquisitionsOPKO HealthPharmaceutical

780 to 804 of 930 results



Back to top